Department of Trauma and Orthopaedics, Academic Unit, Clarendon Wing, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
BMC Med. 2011 May 31;9:66. doi: 10.1186/1741-7015-9-66.
Bone regeneration is a complex, well-orchestrated physiological process of bone formation, which can be seen during normal fracture healing, and is involved in continuous remodelling throughout adult life. However, there are complex clinical conditions in which bone regeneration is required in large quantity, such as for skeletal reconstruction of large bone defects created by trauma, infection, tumour resection and skeletal abnormalities, or cases in which the regenerative process is compromised, including avascular necrosis, atrophic non-unions and osteoporosis. Currently, there is a plethora of different strategies to augment the impaired or 'insufficient' bone-regeneration process, including the 'gold standard' autologous bone graft, free fibula vascularised graft, allograft implantation, and use of growth factors, osteoconductive scaffolds, osteoprogenitor cells and distraction osteogenesis. Improved 'local' strategies in terms of tissue engineering and gene therapy, or even 'systemic' enhancement of bone repair, are under intense investigation, in an effort to overcome the limitations of the current methods, to produce bone-graft substitutes with biomechanical properties that are as identical to normal bone as possible, to accelerate the overall regeneration process, or even to address systemic conditions, such as skeletal disorders and osteoporosis.
骨再生是一个复杂的、协调良好的骨形成生理过程,可在正常骨折愈合过程中观察到,并且在整个成年期都参与持续的重塑。然而,在一些复杂的临床情况下,需要大量的骨再生,例如创伤、感染、肿瘤切除和骨骼畸形造成的大骨缺损的骨骼重建,或者再生过程受损的情况,包括缺血性坏死、萎缩性骨不连和骨质疏松症。目前,有大量不同的策略来增强受损或“不足”的骨再生过程,包括“金标准”自体骨移植物、游离腓骨血管化移植物、同种异体植入物以及生长因子、骨传导支架、成骨前体细胞和牵张成骨的应用。在组织工程和基因治疗方面的改进“局部”策略,甚至是“全身性”增强骨修复,正在进行深入研究,以努力克服当前方法的局限性,生产出具有尽可能与正常骨相同的生物力学特性的骨移植物替代品,加速整体再生过程,甚至解决骨骼疾病和骨质疏松症等系统性疾病。